← board
BFRG
distress 6/10 · elevated risk$0.63-1%today-62% from 52w high
Lead: pancreatic cancer · est. market ~$5B (approx, global)
Revenue
pre-revenue
Liquidity
$5M
Runway
1.0 yrs
Shares 1y
+84%
Price & events
-23.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.8%
1D
-0.3%
1W
-4.8%
1M
-25.2%
3M
-12.7%
6M
-59.4%
1Y
-80.1%
2Y
—
5Y
-90.3%
All
Overview
- Market Cap
- $11.68M
- Volume
- 28.61K
- 52 Week Range
- $0.46 – $1.68
- Total Shares
- 18.54M
- Float Shares
- 16.11M
- Short %
- 1.44%
- % Held by Insiders
- 13.16%
- % Held by Institutions
- 2.94%
- RVOL
- 0.16x
- Beta
- -2.81
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2027Guided 40%enrollment completesecondaryPhase 3glufosfamide · Eleison expects to complete ongoing Phase 3 trialSEC 8-K
- January 9, 2026conferencedata presentationsecondaryPhase 3Presentation of results from Eleison collaboration at ASCO Gastrointestinal Cancers SymposiumSEC 8-K
- 2025-02-27partnershipCollaboration agreement with Eleison Pharmaceuticals to apply BullFrog Data Networks for trial optimizationSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 18,541,651 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $ · analysts
- no recent rating changes
Competitors — pancreatic cancer
- LLYELI LILLY & Co$1094.4B · D3
- RVMDRevolution Medicines, Inc.$40.3B · D1
- JAZZJazz Pharmaceuticals plc$15.7B · D0
- IBRXImmunityBio, Inc.$7.8B · D5
- TNGXTango Therapeutics, Inc.$4.0B · D5
- MNPRMonopar Therapeutics$687M · D1
- IMRXImmuneering Corp$112M · D3
- RNXTRenovoRx, Inc.$39M · D5
- SLXNSilexion Therapeutics Corp$10M · D6
- AZNASTRAZENECA PLC— · D3
Recent news
- 2026-07-22AI company BullFrog AI sets online investor meetings for July 29 - Stock Titan
- 2026-07-22BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference - Yahoo Finance
- 2026-07-21BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026 - The Manila Times
- 2026-07-21BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026 - The Manila Times
- 2026-07-18Bullfrog AI Holdings Inc. (BFRG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
- 2026-07-12Price to sales forward of Bullfrog AI Holdings, Inc. – NASDAQ:BFRG - TradingView
- 2026-06-15BullFrog AI (NASDAQ: BFRG) director receives 15,000 stock options as compensation grant - Stock Titan
- 2026-06-15BullFrog AI (BFRG) grants director Jason Hanson 15,000 stock options - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.